4-(1,5-dimethylpyrazol-4-yl)-5-(4H-imidazol-2-yl)-2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole;N-[4-[5-(1H-imidazol-2-yl)-4-(3-methoxyphenyl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;4-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]butan-1-amine;5-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]pentan-1-amine;4-[5-[2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-5-(1H-1,2,4-triazol-5-yl)-1,3-thiazol-4-yl]-2-pyridinyl]morpholine

C110H104N32O3S5 — CID 161012940

IUPAC4-(1,5-dimethylpyrazol-4-yl)-5-(4H-imidazol-2-yl)-2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole;N-[4-[5-(1H-imidazol-2-yl)-4-(3-methoxyphenyl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;4-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]butan-1-amine;5-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]pentan-1-amine;4-[5-[2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-5-(1H-1,2,4-triazol-5-yl)-1,3-thiazol-4-yl]-2-pyridinyl]morpholine
SMILESCOc1cccc(-c2nc(-c3ccnc(NC(C)=O)c3)sc2-c2ncc[nH]2)c1.Cc1nc2ccc(CCCCCN)cn2c1-c1nc(-c2ccccc2)c(-c2ncc[nH]2)s1.Cc1nc2ccc(CCCCN)cn2c1-c1nc(-c2ccccc2)c(-c2ncc[nH]2)s1.Cc1nn2ccccc2c1-c1nc(-c2ccc(N3CCOCC3)nc2)c(-c2ncn[nH]2)s1.Cc1nn2ccccc2c1-c1nc(-c2cnn(C)c2C)c(C2=NCC=N2)s1
InChIInChI=1S/C25H26N6S.C24H24N6S.C22H20N8OS.C20H17N5O2S.C19H17N7S/c1-17-22(31-16-18(8-4-3-7-13-26)11-12-20(31)29-17)25-30-21(19-9-5-2-6-10-19)23(32-25)24-27-14-15-28-24;1-16-21(30-15-17(7-5-6-12-25)10-11-19(30)28-16)24-29-20(18-8-3-2-4-9-18)22(31-24)23-26-13-14-27-23;1-14-18(16-4-2-3-7-30(16)28-14)22-26-19(20(32-22)21-24-13-25-27-21)15-5-6-17(23-12-15)29-8-10-31-11-9-29;1-12(26)24-16-11-14(6-7-21-16)20-25-17(13-4-3-5-15(10-13)27-2)18(28-20)19-22-8-9-23-19;1-11-15(14-6-4-5-9-26(14)24-11)19-23-16(13-10-22-25(3)12(13)2)17(27-19)18-20-7-8-21-18/h2,5-6,9-12,14-16H,3-4,7-8,13,26H2,1H3,(H,27,28);2-4,8-11,13-15H,5-7,12,25H2,1H3,(H,26,27);2-7,12-13H,8-11H2,1H3,(H,24,25,27);3-11H,1-2H3,(H,22,23)(H,21,24,26);4-7,9-10H,8H2,1-3H3
InChIKeyTXJAZUUAKDPQOR-UHFFFAOYSA-N
MW2082.60 g/mol
LogP21.58
Rot. Bonds27

About 4-(1,5-dimethylpyrazol-4-yl)-5-(4H-imidazol-2-yl)-2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole;N-[4-[5-(1H-imidazol-2-yl)-4-(3-methoxyphenyl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;4-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]butan-1-amine;5-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]pentan-1-amine;4-[5-[2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-5-(1H-1,2,4-triazol-5-yl)-1,3-thiazol-4-yl]-2-pyridinyl]morpholine

4-(1,5-dimethylpyrazol-4-yl)-5-(4H-imidazol-2-yl)-2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole;N-[4-[5-(1H-imidazol-2-yl)-4-(3-methoxyphenyl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;4-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]butan-1-amine;5-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]pentan-1-amine;4-[5-[2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-5-(1H-1,2,4-triazol-5-yl)-1,3-thiazol-4-yl]-2-pyridinyl]morpholine (PubChem CID 161012940) has the molecular formula C110H104N32O3S5 and a molecular weight of 2082.60 g/mol. Its IUPAC name is 4-(1,5-dimethylpyrazol-4-yl)-5-(4H-imidazol-2-yl)-2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole;N-[4-[5-(1H-imidazol-2-yl)-4-(3-methoxyphenyl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;4-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]butan-1-amine;5-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]pentan-1-amine;4-[5-[2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-5-(1H-1,2,4-triazol-5-yl)-1,3-thiazol-4-yl]-2-pyridinyl]morpholine.

Molecular Properties

Compound Name4-(1,5-dimethylpyrazol-4-yl)-5-(4H-imidazol-2-yl)-2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole;N-[4-[5-(1H-imidazol-2-yl)-4-(3-methoxyphenyl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;4-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]butan-1-amine;5-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]pentan-1-amine;4-[5-[2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-5-(1H-1,2,4-triazol-5-yl)-1,3-thiazol-4-yl]-2-pyridinyl]morpholine
PubChem CID161012940
Molecular FormulaC110H104N32O3S5
Molecular Weight2082.60 g/mol
Exact Mass2080.76
IUPAC Name4-(1,5-dimethylpyrazol-4-yl)-5-(4H-imidazol-2-yl)-2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole;N-[4-[5-(1H-imidazol-2-yl)-4-(3-methoxyphenyl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;4-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]butan-1-amine;5-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]pentan-1-amine;4-[5-[2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-5-(1H-1,2,4-triazol-5-yl)-1,3-thiazol-4-yl]-2-pyridinyl]morpholine
SMILESCOc1cccc(-c2nc(-c3ccnc(NC(C)=O)c3)sc2-c2ncc[nH]2)c1.Cc1nc2ccc(CCCCCN)cn2c1-c1nc(-c2ccccc2)c(-c2ncc[nH]2)s1.Cc1nc2ccc(CCCCN)cn2c1-c1nc(-c2ccccc2)c(-c2ncc[nH]2)s1.Cc1nn2ccccc2c1-c1nc(-c2ccc(N3CCOCC3)nc2)c(-c2ncn[nH]2)s1.Cc1nn2ccccc2c1-c1nc(-c2cnn(C)c2C)c(C2=NCC=N2)s1
InChIInChI=1S/C25H26N6S.C24H24N6S.C22H20N8OS.C20H17N5O2S.C19H17N7S/c1-17-22(31-16-18(8-4-3-7-13-26)11-12-20(31)29-17)25-30-21(19-9-5-2-6-10-19)23(32-25)24-27-14-15-28-24;1-16-21(30-15-17(7-5-6-12-25)10-11-19(30)28-16)24-29-20(18-8-3-2-4-9-18)22(31-24)23-26-13-14-27-23;1-14-18(16-4-2-3-7-30(16)28-14)22-26-19(20(32-22)21-24-13-25-27-21)15-5-6-17(23-12-15)29-8-10-31-11-9-29;1-12(26)24-16-11-14(6-7-21-16)20-25-17(13-4-3-5-15(10-13)27-2)18(28-20)19-22-8-9-23-19;1-11-15(14-6-4-5-9-26(14)24-11)19-23-16(13-10-22-25(3)12(13)2)17(27-19)18-20-7-8-21-18/h2,5-6,9-12,14-16H,3-4,7-8,13,26H2,1H3,(H,27,28);2-4,8-11,13-15H,5-7,12,25H2,1H3,(H,26,27);2-7,12-13H,8-11H2,1H3,(H,24,25,27);3-11H,1-2H3,(H,22,23)(H,21,24,26);4-7,9-10H,8H2,1-3H3
InChIKeyTXJAZUUAKDPQOR-UHFFFAOYSA-N
XLogP21.58
TPSA432.42 Ų
H-Bond Donors7
H-Bond Acceptors35
Rotatable Bonds27
Heavy Atoms150
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002082.60
LogP ≤ 521.58
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1035

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 4-(1,5-dimethylpyrazol-4-yl)-5-(4H-imidazol-2-yl)-2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole;N-[4-[5-(1H-imidazol-2-yl)-4-(3-methoxyphenyl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;4-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]butan-1-amine;5-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]pentan-1-amine;4-[5-[2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-5-(1H-1,2,4-triazol-5-yl)-1,3-thiazol-4-yl]-2-pyridinyl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-(1,5-dimethylpyrazol-4-yl)-5-(4H-imidazol-2-yl)-2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole;N-[4-[5-(1H-imidazol-2-yl)-4-(3-methoxyphenyl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;4-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]butan-1-amine;5-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]pentan-1-amine;4-[5-[2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-5-(1H-1,2,4-triazol-5-yl)-1,3-thiazol-4-yl]-2-pyridinyl]morpholine?
The IUPAC name of 4-(1,5-dimethylpyrazol-4-yl)-5-(4H-imidazol-2-yl)-2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole;N-[4-[5-(1H-imidazol-2-yl)-4-(3-methoxyphenyl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;4-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]butan-1-amine;5-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]pentan-1-amine;4-[5-[2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-5-(1H-1,2,4-triazol-5-yl)-1,3-thiazol-4-yl]-2-pyridinyl]morpholine (CID 161012940) is 4-(1,5-dimethylpyrazol-4-yl)-5-(4H-imidazol-2-yl)-2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole;N-[4-[5-(1H-imidazol-2-yl)-4-(3-methoxyphenyl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;4-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]butan-1-amine;5-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]pentan-1-amine;4-[5-[2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-5-(1H-1,2,4-triazol-5-yl)-1,3-thiazol-4-yl]-2-pyridinyl]morpholine.
What is the SMILES notation for 4-(1,5-dimethylpyrazol-4-yl)-5-(4H-imidazol-2-yl)-2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole;N-[4-[5-(1H-imidazol-2-yl)-4-(3-methoxyphenyl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;4-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]butan-1-amine;5-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]pentan-1-amine;4-[5-[2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-5-(1H-1,2,4-triazol-5-yl)-1,3-thiazol-4-yl]-2-pyridinyl]morpholine?
The canonical SMILES for 4-(1,5-dimethylpyrazol-4-yl)-5-(4H-imidazol-2-yl)-2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole;N-[4-[5-(1H-imidazol-2-yl)-4-(3-methoxyphenyl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;4-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]butan-1-amine;5-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]pentan-1-amine;4-[5-[2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-5-(1H-1,2,4-triazol-5-yl)-1,3-thiazol-4-yl]-2-pyridinyl]morpholine is COc1cccc(-c2nc(-c3ccnc(NC(C)=O)c3)sc2-c2ncc[nH]2)c1.Cc1nc2ccc(CCCCCN)cn2c1-c1nc(-c2ccccc2)c(-c2ncc[nH]2)s1.Cc1nc2ccc(CCCCN)cn2c1-c1nc(-c2ccccc2)c(-c2ncc[nH]2)s1.Cc1nn2ccccc2c1-c1nc(-c2ccc(N3CCOCC3)nc2)c(-c2ncn[nH]2)s1.Cc1nn2ccccc2c1-c1nc(-c2cnn(C)c2C)c(C2=NCC=N2)s1.
What is the InChIKey of 4-(1,5-dimethylpyrazol-4-yl)-5-(4H-imidazol-2-yl)-2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole;N-[4-[5-(1H-imidazol-2-yl)-4-(3-methoxyphenyl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;4-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]butan-1-amine;5-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]pentan-1-amine;4-[5-[2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-5-(1H-1,2,4-triazol-5-yl)-1,3-thiazol-4-yl]-2-pyridinyl]morpholine?
The InChIKey is TXJAZUUAKDPQOR-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H26N6S.C24H24N6S.C22H20N8OS.C20H17N5O2S.C19H17N7S/c1-17-22(31-16-18(8-4-3-7-13-26)11-12-20(31)29-17)25-30-21(19-9-5-2-6-10-19)23(32-25)24-27-14-15-28-24;1-16-21(30-15-17(7-5-6-12-25)10-11-19(30)28-16)24-29-20(18-8-3-2-4-9-18)22(31-24)23-26-13-14-27-23;1-14-18(16-4-2-3-7-30(16)28-14)22-26-19(20(32-22)21-24-13-25-27-21)15-5-6-17(23-12-15)29-8-10-31-11-9-29;1-12(26)24-16-11-14(6-7-21-16)20-25-17(13-4-3-5-15(10-13)27-2)18(28-20)19-22-8-9-23-19;1-11-15(14-6-4-5-9-26(14)24-11)19-23-16(13-10-22-25(3)12(13)2)17(27-19)18-20-7-8-21-18/h2,5-6,9-12,14-16H,3-4,7-8,13,26H2,1H3,(H,27,28);2-4,8-11,13-15H,5-7,12,25H2,1H3,(H,26,27);2-7,12-13H,8-11H2,1H3,(H,24,25,27);3-11H,1-2H3,(H,22,23)(H,21,24,26);4-7,9-10H,8H2,1-3H3.
What are the key properties of 4-(1,5-dimethylpyrazol-4-yl)-5-(4H-imidazol-2-yl)-2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole;N-[4-[5-(1H-imidazol-2-yl)-4-(3-methoxyphenyl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;4-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]butan-1-amine;5-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]pentan-1-amine;4-[5-[2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-5-(1H-1,2,4-triazol-5-yl)-1,3-thiazol-4-yl]-2-pyridinyl]morpholine?
4-(1,5-dimethylpyrazol-4-yl)-5-(4H-imidazol-2-yl)-2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole;N-[4-[5-(1H-imidazol-2-yl)-4-(3-methoxyphenyl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;4-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]butan-1-amine;5-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]pentan-1-amine;4-[5-[2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-5-(1H-1,2,4-triazol-5-yl)-1,3-thiazol-4-yl]-2-pyridinyl]morpholine has a molecular weight of 2082.60 g/mol, XLogP of 21.58, 27 rotatable bonds, 7 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(1,5-dimethylpyrazol-4-yl)-5-(4H-imidazol-2-yl)-2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole;N-[4-[5-(1H-imidazol-2-yl)-4-(3-methoxyphenyl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;4-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]butan-1-amine;5-[3-[5-(1H-imidazol-2-yl)-4-phenyl-1,3-thiazol-2-yl]-2-methylimidazo[1,2-a]pyridin-6-yl]pentan-1-amine;4-[5-[2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-5-(1H-1,2,4-triazol-5-yl)-1,3-thiazol-4-yl]-2-pyridinyl]morpholine is sourced from PubChem (CID 161012940), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).